- [GERP] 유전자편집·제어·복원기반기술개발사업 성과 누계 2025-04-07
- [논문] Clinical Characterization, Natural History, and Detailed Phenotyping of NMNAT1-Associated Leber Congenital Amaurosis 2025-04-07
- [논문] Genotype-Phenotype Correlations in 83 Korean X-linked Retinoschisis Patients: Impact of Retinoschisin 1 Secretion Profiles on Clinical Phenotypes 2025-04-07
- [논문] CaV3.3 T-type calcium channels contribute to carboplatin resistance in retinoblastoma 2025-04-07
- [논문] Biallelic variants of SEMA3F are associated with nonsyndromic hearing loss 2025-04-07
- [논문] Consolidate Overview of Ribonucleic Acid Molecular Dynamics: From Molecular Movements to Material Innovations 2025-04-07
- [논문] Single-molecule FRET–based approach for protein-targeted drug discovery 2025-04-07
- [논문] Engineered lipid nanoparticles enable therapeutic gene silencing of GTSE1 for the treatment of liver fibrosis 2025-04-07
- [Market] 글로벌 유전자 치료 시장의 현황 및 전망 2025-05-30
- [R&D] Autophagy induction enhances homologous recombination-associated CRISPR–Cas9 gene editing 2025-05-27
- [R&D] Variant-aware Cas-OFFinder: web-based in silico variant-aware potential off-target site identification for genome editing applications 2025-05-20
- [R&D] Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease 2025-05-19
- [R&D] 첨단바이오포커스 제51호 key issue - 유전자가위 기반 치료 2025-05-19
- [R&D] RiboJ-assisted non-repeated sgRNA arrays for enhanced CRISPR multiplex genome engineering in Escherichia coli 2025-04-28
- [Market] 글로벌 세포‧유전자 치료제 마켓 연평균 44% 급성장 2025-04-15
- [Market] 세포·유전자치료제 임상환자 투약, 원가 기준 만든다 2025-04-15
- 2025 IBS-GERP 공동 성과교류회 개최 안내 2025-02-14
- 2024 성과교류회 개최 안내 2024-08-13
- 2024 연구자 워크숍 성료 2024-07-01
- 2024 연구자 워크숍 - 프로그램(안)_6/11 수정 2024-04-23